Bextra News and Discussions

Bextra, the COX-2 inhibitor painkiller, manufactured by Pfizer was pulled from the market last Thursday due to FDA concerns over increased risk of heart attack and stroke, along with a rare but possibly life threatening skin condition. The FDA and it's European counterpart requested that Pfizer stop all sales in US and Europe. The FDA also ordered that 19 other popular prescription competitors, from Celebrex to high-dose naproxen are to be labeled with tough new warnings of elevated risk of heart attack and stoke.